[Obesity paradox].
Obesity has reached global epidemic proportions and is associated with major cardiovascular diseases and reduced overall survival. This paper reviews the metabolic and vascular consequences of dysfunctional adipocytokines in obesity as well as the pathological effects on blood pressure, cardiovascular structure and function. Despite this adverse association, numerous studies have documented an obesity paradox in which overweight and obese population with established cardiovascular disease have a better prognosis. There are potential explanations offered by literature for these puzzling data. For obese hypertensive patients the paradox is possibly linked to the lower systemic vascular resistance and plasma renin activity. In heart failure the excess body weight may confer some protective effects on mortality, due to a more metabolic reserve, higher levels of arterial pressure compatible with higher doses of cardioprotective medications, and a specific neuroendocrine profile with lower levels of circulating natriuretic atrial peptides, attenuated sympathetic nervous system and renin-angiotensin responses. For coronary heart disease and peripheral arterial disease the mechanisms are still uncertain. There are discussed a lesser severity of coronary lesions and left ventricular dysfunction, or a reduced prevalence of moderate-severe chronic obstructive pulmonary disease in patients selected for surgery. On the other hand, the constellation of data which supports purposeful weight reduction in the prevention and treatment of cardiovascular diseases, induces a controversial position regarding this new concept.
Aursulesei
Viviana
V
Facultatea de Medicină, Clinica I Medicală Cardiologică, Universitatea de Medicină si Farmacie "Gr.T. Popa" Iaşi.
Cozma
A
A
Datcu
M D
MD
D054392:Adipokines / Q000097:blood; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism*; D006801:Humans; D009765:Obesity / Q000097:blood / Q000150:complications / Q000453:epidemiology / Q000378:metabolism*; D015995:Prevalence; D011379:Prognosis; D012307:Risk Factors; D012383:Romania / Q000453:epidemiology; D015431:Weight Loss
D054392:Adipokines; D015415:Biomarkers